Alan J Higgins

Title: Alan J Higgins: Innovator in Pharmaceutical Compositions

Introduction

Alan J Higgins is a notable inventor based in Upper Montclair, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit enzyme carnitine acyltransferase 1 (CAT-1). His work is crucial in addressing issues related to ischemic tissue injury and improving cardiac function.

Latest Patents

Alan J Higgins holds a patent for "Cat-1 inhibitors, pharmaceutical compositions and methods of use." This invention relates to specific compounds that inhibit CAT-1, which are useful in preventing injury to ischemic tissue. The patent details the formula of these compounds and their pharmaceutically acceptable salts, enantiomers, racemates, and other variations. The compounds are designed to limit infarct size, improve cardiac function, and prevent arrhythmias during and after a myocardial infarction. He has 1 patent to his name.

Career Highlights

Higgins has had a distinguished career, working with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His expertise in developing innovative pharmaceutical solutions has made a significant impact on medical treatments.

Collaborations

Throughout his career, Alan J Higgins has collaborated with esteemed colleagues, including Robert W Guthrie and John G Mullin. These partnerships have contributed to the advancement of research and development in the pharmaceutical field.

Conclusion

Alan J Higgins is a prominent inventor whose work in pharmaceutical compositions has the potential to improve cardiac health and treatment outcomes for patients. His contributions to the field are invaluable and continue to influence medical advancements.